» Articles » PMID: 3389849

Pruritus in Psoriasis. A Prospective Study of Some Psychiatric and Dermatologic Correlates

Overview
Journal Arch Dermatol
Specialty Dermatology
Date 1988 Jul 1
PMID 3389849
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Among 82 inpatients with psoriasis, 67% (55 patients) reported moderate or severe pruritus. The degree of depressive psychopathology discriminated between the mild, moderate, and severe pruritus groups at admission. Prospectively, the change in depression scores correlated with the change in pruritus pretreatment to posttreatment. Pruritus severity did not correlate significantly with stress due to life events, age at onset, ethyl duration of psoriasis, age, sex, marital status, and average reported daily alcohol (ethanol) consumption. Among the objective dermatologic measures, including extent and severity of lesions, only the degree of perilesional irritation discriminated between the mild, moderate, and severe pruritus groups at admission, and prospectively, change in this measure correlated with the change in pruritus pretreatment to posttreatment. This finding was most likely related to the self-excoriation associated with pruritus. Intrapsychic factors (eg, the severity of depression) rather than external psychosocial or well-defined dermatologic factors, were the most significant correlates of pruritus in psoriasis.

Citing Articles

The Psoriasis Disability Index in Romanian Psoriasis Patients during COVID-19 Pandemic: Contribution of Clinical and Psychological Variables.

Mihu C, Popescu C, Neag M, Bocsan I, Melincovici C, Baican A J Clin Med. 2023; 12(18).

PMID: 37762940 PMC: 10531900. DOI: 10.3390/jcm12186000.


Human Mast Cells Upregulate Cathepsin B, a Novel Marker of Itch in Psoriasis.

West P, Tontini C, Atmoko H, Kiss O, Garner T, Bahri R Cells. 2023; 12(17).

PMID: 37681909 PMC: 10486964. DOI: 10.3390/cells12172177.


Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial.

Gold L, Alonso-Llamazares J, Draelos Z, Gooderham M, Kempers S, Kircik L Am J Clin Dermatol. 2022; 24(2):305-313.

PMID: 36370336 PMC: 9968264. DOI: 10.1007/s40257-022-00739-3.


Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis.

Taylor P, Bushmakin A, Cappelleri J, Young P, Germino R, Merola J J Clin Med. 2021; 10(18).

PMID: 34575192 PMC: 8472763. DOI: 10.3390/jcm10184081.


A Study of Itch in Psoriasis.

Meena M, Maheshwari K, Vyas K, Mittal A Indian Dermatol Online J. 2021; 12(3):477-479.

PMID: 34211926 PMC: 8202493. DOI: 10.4103/idoj.IDOJ_571_20.